Trials / Completed
CompletedNCT02826382
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
A Preliminary Evaluation of Uptake in Bone Metastases, Biodistribution and Excretion of the Novel Radiotracer [68Ga]P15-041 by PET/CT
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Five Eleven Pharma, Inc. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A phase1 study to demonstrate \[68Ga\]P15-041 binding to bone metastases in prostate cancer and determination of human dosimetry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [68Ga]P15-041 | Imaging by Positron Emission Tomography after injection of \[68Ga\]P15-041 |
Timeline
- Start date
- 2016-09-20
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2016-07-11
- Last updated
- 2023-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02826382. Inclusion in this directory is not an endorsement.